BioNTech
BNTX
252 hedge funds and large institutions have $4.05B invested in BioNTech in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 81 increasing their positions, 85 reducing their positions, and 54 closing their positions.
5% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 85
1.1% less ownership
Funds ownership: 16.52% → 15.42% (-1.1%)
10% less funds holding
Funds holding: 281 → 252 (-29)
17% less capital invested
Capital invested by funds: $4.88B → $4.05B (-$825M)
31% less call options, than puts
Call options by funds: $201M | Put options by funds: $291M
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
52% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 54
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$21.1M |
| 2 |
Voloridge Investment Management
Jupiter,
Florida
|
+$20.5M |
| 3 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$17.9M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$17.3M |
| 5 |
Temasek Holdings
Singapore
|
+$15.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$108M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$65.3M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$52.4M |
| 4 |
Morgan Stanley
New York
|
-$43.7M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$24.5M |
BNTX Hedge Fund Activity: Q2 2023 in Review
252 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q2 2023, worth a combined $4.05B — down 17% from $4.88B a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of BNTX and 26 opened new positions — a net loss of 28 holders — while 85 trimmed existing stakes and 81 added.
The largest buyer was Citadel Advisors, adding an estimated $21.1M. The largest seller was Envestnet Asset Management, cutting an estimated $108M.
- 252 institutional investors held BioNTech (BNTX) as of Q2 2023, down from 281 in Q1 2023.
- Funds reported $4.05B of BioNTech stock for Q2 2023, down 17% quarter-over-quarter.
- 26 funds opened new BioNTech positions in Q2 2023 and 54 closed out, a net change of -28 holders.
- The largest BioNTech buyer in Q2 2023 was Citadel Advisors, an estimated $21.1M added.
- The largest BioNTech seller in Q2 2023 was Envestnet Asset Management, an estimated $108M sold.
Based on aggregated 13F filings for Q2 2023.